Abstract Supv3L1 is a conserved and ubiquitously expressed helicase found in numerous tissues and cell types of many species. In human cells, SUPV3L1 was shown to suppress apoptotic death and sister chromatid exchange, and impair mitochondrial RNA metabolism and protein synthesis. In vitro experiments revealed binding of SUPV3L1 to BLM and WRN proteins, suggesting a role in genome maintenance processes.
Introduction
First described in yeast Conrad-Webb et al. 1990; Zhu et al. 1989) , the SUV3 gene was later found to be conserved throughout evolution, with orthologs documented in bacteria, plants, nematodes, Drosophila, and mammals (Dmochowska et al. 1999) . The yeast SUV3 protein localizes primarily in the mitochondrial matrix and displays RNA helicase activity (Stepien et al. 1992) . Together with the ribonuclease DSS1, SUV3 forms a RNA degradosome complex (Dziembowski et al. 2003 ) that affects a variety of mitochondrial processes. The mammalian ortholog of the SUV3 gene, designated Supv3L1, is a member of the Ski2 family of DExH-box RNA helicases and has been shown in vitro to possess both RNA/RNA and DNA/DNA unwinding activities (Minczuk et al. 2002; Shu et al. 2004) . Although originally thought to be exclusively mitochondrial, recent evidence suggests that Supv3L1 may function in both mitochondria and the nucleus (Minczuk et al. 2005; Shu et al. 2004; Szczesny et al. 2007) to modulate key cellular processes such as apoptosis ), transcription, recombination, and replication (Pereira et al. 2007 ). The predominant role of Supv3L1, however, correlates with its mitochondrial localization where it constitutes an important part of the RNA degradosome complex, whose impairment affects mitochondrial protein synthesis, reactive oxygen species (ROS) generation, ATP synthesis, and mtDNA copy number (Khidr et al. 2008) . The documented in vitro interaction of human SUPV3L1 with the BLM and WRN proteins (Pereira et al. 2007 ) raises the possibility that SUPV3L1 may cooperate with other genome integrity housekeepers and play an important role in genome repair and maintenance processes.
We previously reported that mouse Supv3L1 is an important developmentally regulated gene whose disruption leads to early embryonic lethality (Pereira et al. 2007) . In this article, using a conditional knockout strategy, we present evidence for key functions of the gene in several adult tissues. Together, these results demonstrate that conditional disruption of Supv3L1 leads to a premature aging phenotype, including profound skin defects resembling those found in several human skin disorders. Specifically, the Supv3L1 helicase appears to be a contributing factor in the development of ichthyosis and psoriasis-like changes.
Materials and methods

Targeting vector construction
Genomic DNA for vector construction was derived from MICER MHPN407c19 vector, obtained from The Welcome Trust Sanger Institute (Adams et al. 2004 ). The mouse genomic segment of MHPN407c19 spans 8.9 kb and includes exons 13-16 of the Supv3L1 gene [NCBI GeneID 338359] . The MICER vector was first cleaved with XhoI to remove a 5.5-kb fragment containing Neo resistance, and the resulting plasmid (MHPN407c19DXhoI) was used for further modifications. The final targeting vector, pDXhoFNFL14L, was obtained using recombineering methods (Liu et al. 2003; Warming et al. 2005) and contains a floxed exon 14 and a Neo cassette flanked with Frt sites (Fig. 1a) .
Gene targeting of ES cells
129Ola embryonic stem (ES) cells derived from a male embryo were grown on mitotically inactive SNL76/7 feeder cells. Ten million (10 7 ) ES cells were electroporated with 20 lg of pDXhoFNFL13L linearized with AscI, and G418 selection was initiated after 24 h. Two hundred G418-resistant clones were selected for further analysis. Correctly targeted ES cell clones (Fig. 1b, c) were identified as described (Klysik and Singer 2005; Ramirez-Solis et al. 1995) .
Generation of mice
All breeding and procedures were carried out at the Brown University Animal Facility according to institutional regulations and the NIH Guide for the Use and Care of Laboratory Animals. Targeted ES cells were grown to 90% confluency and harvested by trypsinization for injection. E3.5 blastocysts were derived from C57BL/C2J female mice and injected with 12-20 ES cells. The injected blastocysts were implanted into the uteri of day 2.5 pseudopregnant females for the generation of chimeras. Eight to ten injected embryos were implanted per uterine horn. The male chimeras were mated with C57BL/C2J females to obtain F1 progeny. Germ line transmission of the floxed allele, designated Supv3L1 tm2Jkl (Fig. 1a) , was obtained with several targeted cell lines. Heterozygous Supv3L1 tm2Jkl mice were mated with B6.FVB-Tg(EIIa-cre) C5379Lmgd/J (The Jackson Laboratory, Bar Harbor, ME) to obtain the Supv3L1 tm5Jkl (D14) allele, or with 129S4/ SVJaeSor-Gt(ROSA)26Sor
tm1 ( animals and the Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl genotype was selected. KRT14-Cre Supv3L1 tm3Jkl/tm4Jkl mice were obtained using a similar mating strategy and the Tg(KRT14-cre/Esr1)20Efu/J strain (The Jackson Laboratory). All alleles were maintained on a mixed 129/BL6 background. Because the Supv3L1 tm2Jkl and Supv3L1 tm3Jkl alleles were found to be indistinguishable in genetic crosses, survival rates, and pathologic assays, they are occasionally referred to as the Supv3L1 floxed allele. Similarly, Supv3L1 tm4Jkl and Supv3L1 tm5Jkl alleles were not distinguishable and are occasionally referred to as minus (-) allele.
Genotyping
Genomic DNA was prepared from ES cells, tail biopsies, or tissues, and PCR was performed using the primers shown in Fig. 1d . Amplification conditions for fragments not exceeding 1 kb consisted of an initial incubation at 94°C for 2 min, followed by 35 cycles at 94°C for 30 s, 60°C for 30 s, and 72°C for 60 s. For longer products, the extension time at 72°C was increased by 1 min/kb.
Genotyping by Southern blotting was performed using a 598-bp PCR-generated probe (primers: AGTACTCAA GGCCAACTCTCCAACGCACC and TTCATGAAGAC TGGCCTAAGGCAGACTTC) (Fig. 1b) .
Tamoxifen administration 4-Hydroxy tamoxifen (Sigma, St. Louis, MO) was prepared in ethanol at a concentration of 5 mg/ml. Forty microliters of this solution was applied daily for 5 days on a shaved surface of the back skin. For subcutaneous injections, Fig. 1 tamoxifen was dissolved overnight in corn oil (Sigma) at a concentration of 20 mg/ml. The administration schedule consisted of five consecutive daily injections of 0.05 mg/g body weight.
Tissue processing and staining Tissues from experimental and control littermate animals used in these studies were matched according to sex and age. Tissues were dissected out, fixed in 5% formaldehyde in phosphate-buffered saline (PBS) at 4°C, and embedded in paraffin. Hematoxylin and eosin (H&E) staining was performed by standard procedures (Xia et al. 1999) . Histologic sections of tissues were analyzed by trained pathologists in a blinded fashion.
TUNEL assay TUNEL staining for apoptotic nuclei was performed using the ApopTag Peroxidase in situ apoptosis detection kit (Millipore, Billerica, MA) according to the manufacturer's instructions. Labeling reactions were performed for 60 min at 37°C in a humidified chamber. Color development was accomplished using 3,3 0 -diaminobenzidine for 5 min. Sections were counterstained with methyl green.
Flow cytometry
Single-cell suspensions from thymus and spleen were prepared by disaggregation. Cells were washed twice with FACS wash buffer (HBSS containing 1% BSA). Before the staining, Fc-receptors were blocked for 15 min at 4°C with anti-Fc receptor monoclonal antibody 2.4G2. Cells were then stained with monoclonal antibodies reactive with the following surface proteins: CD4, CD8, CD24, CD25, CD44, CD45, CD69, TCRb, TCRcd, and Thy1.2. The stained cells were analyzed on a LSRII instrument (BD Biosciences, San Jose, CA), using FlowJo software (Tree Star, Inc., Ashland, OR). Dead cells were excluded by propidium iodide staining.
Results
Deletion of exon 14 of the Supv3L1 gene causes lethality of homozygous embryos
We previously reported that mice heterozygous for an insertional mutation of Supv3L1 (Supv3L1 tm1Jkl/? ) affecting exons 11-16 are normal and fertile, while homozygous mutants displayed an early embryonic lethality (Pereira et al. 2007 ). The reported gene disruption also caused partial lethality of heterozygous embryos. To circumvent embryonic lethality, we developed a conditional strain carrying a floxed exon 14 of the Supv3L1 gene. alleles as recessive hypomorphs, and this behavior is similar to the insertional mutation of Supv3L1 described previously (Pereira et al. 2007 ). Hypomorphism appears to be the main genetic mechanism behind embryonic lethality of Supv3L1 tm4Jkl/tm4Jkl and Supv3L1 tm5Jkl/tm5Jkl embryos as well as conditionally induced phenotypes reported below.
Genetic crosses to produce Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl mice
The mouse Mx1 gene is part of the viral defense system that is normally silent in healthy mice (Arnheiter et al. 1990; Horisberger and De Staritzky 1989) . In the B6.CgTg(Mx1-cre)1Cgn/J transgenic strain (allele referred to hereafter as Mx1-Cre), the Mx1 promoter drives the widespread expression of Cre. The Mx1 promoter can be induced to high levels by administration of interferon a, interferon b, or synthetic double-stranded RNA (Kuhn et al. 1995; Schneider et al. 2003) . The genomic localization of the Mx1-Cre transgene was unknown at the time these studies were initiated. and Supv3L1 tm2Jkl/? genotypes to arise solely by meiotic crossover. The position of the Supv3L1 gene is known (chromosome 10). We therefore established that the Mx1-Cre transgene is located on the same chromosome at a distance of approximately 2.5 cM (5 Mb). To confirm close proximity of the genes and to improve future production of experimental Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animals, we backcrossed Mx1-Cre Supv3L1 tm2Jkl/? males to C57BL/6-Tyr c-Brd females. Among 67 pups genotyped, one was found positive for Mx1-Cre and Supv3L1 tm2Jkl , confirming that a crossover had occurred between the two loci. All together, six Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animals were obtained from crosses of Mx1-Cre Supv3L1 tm2Jkl/? and Supv3L1 tm2Jkl/tm2Jkl mice and analyzed.
Mx1-Cre-driven Supv3L1 deletion leads to a postnatal developmental delay, skin defects, and death
The Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animals appeared normal at birth and developed normally over the first 2 weeks of life. However, at weaning, signs of a developmental delay tm2Jkl/tm2Jkl animal at 10 weeks of age. c Formation of scales on feet of a Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animal at 10 weeks of age (left) relative to a normal mouse (right) of the same age. d Typical appearance of an Actb-Cre Supv3L1 tm3Jkl/tm4Jkl animal without tamoxifen administration at the age of 10 weeks showing kyphosis, sarcopenia, and no subcutaneous fat deposits. The same phenotype develops in Actb-Cre Supv3L1 tm2Jkl/tm2Jkl mice (not shown). e Thymic atrophy in an ActbCre Supv3L1 tm3Jkl/tm4Jkl animal (left) relative to a normal thymus (right) from an Actb-Cre Supv3L1 tm3Jkl/? littermate of the same sex (female) and age. f Kyphosis of an Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl
animal after subcutaneous injection of tamoxifen. Note no apparent hair loss. g After subcutaneous injection of tamoxifen, about 35% of Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl mice develop scaling on their feet and tails but not on the body skin became apparent, manifested by slower growth, an abnormal appearance and density of coat hairs, and abnormally flattened and disfigured ears compared to the WT, Supv3L1 tm2Jkl/? , Mx1-Cre Supv3L1 tm2Jkl/? , or Supv3L1 tm2Jkl/tm2Jkl littermates (Fig. 2a) . The feature of flattened and disfigured ears was used for convenient visual genotyping. At the age of 4 weeks the Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animals were about half the size of normal littermates of other genotypes (Fig. 3a) . A profound scaling of the skin (ichthyosis), (Fig. 2b) , feet ( Fig. 2c) , tail, and ears developed along with alopecia ( Fig. 2b) , particularly affecting animals older than 6 weeks of age. While some animals became moribund at 4 weeks, others lived up to 10 weeks. At the time of death, all displayed adipose tissue and muscular atrophy, cachectic appearance, and failing locomotor functions. Mild kyphosis was also observed, particularly among the longer-lived individuals. The affected mice fed and drank frequently until moribund.
The shortened lifespan of Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl mice ( Fig. 4a ) correlated with progressive loss of exon 14. Tail biopsies taken 16, 27, and 31 days after birth revealed partial but increasing loss of exon 14 (Fig. 5a ). Although quantitative monitoring of gene inactivation using PCR presents obvious limitations, it nevertheless provided clear evidence that noninduced [no poly(I-C) injections were performed] and progressive deletion of exon 14 was occurring. The apparent Cre activation could be attributed to either Mx1 promoter leakage or endogenous production of interferon(s). The degree of exon 14 removal differed between various cell types and organs, but all tissues were found to have some floxed allele deleted (Fig. 5b ). Most notably, however, skin cells were almost totally depleted of exon 14. and Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl mice. animals after subcutaneous tamoxifen administration. e The deletion status of the Supv3L1 allele in the skin of animals before 4-hydroxy tamoxifen application (-) and after (?), as assessed by PCR. Note virtually complete deletion of exon 14 in both genotypes. f The deletion status of the floxed Supv3L1 alleles in different tissues of Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl animals after topical 4-hydroxy tamoxifen administration. Topical application of 4-hydroxy tamoxifen using Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl and Actb-Esr1/Cre Supv3L1 tm3Jkl/? animals led to the same response
Testes and cerebellum appeared to display the lowest levels of Mx1-Cre-mediated gene damage. Pathologic examination of deceased mice failed to reveal abnormalities pointing toward a cause of death. Because animals of other genotypes (i.e., Mx1-Cre Supv3L1 tm2Jkl/? , Supv3L1 tm2Jkl/? , Supv3L1 tm2Jkl/tm2Jkl ) were normal and because of prominent signs of starvation such as adipose tissue loss, sarcopenia, and cachexia, the multiple organ failure, including skin defects, could contribute to the death of Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl mice. As the exon 14 deletion was most extensive in the skin, the pathologic changes in this organ were the most early noticeable by simple visual examination.
Mx1-Cre-driven histologic abnormalities in the skin Histologic examination of skin sections revealed numerous defects. The epidermis of Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl mice showed acanthosis (an increase in the thickness of the stratum spinosum), severe hyperkeratosis (a thickened stratum corneum), and hypergranulosis (an increased thickness of the granular layer) (Fig. 6a-c) . Atrophy of the dermis, muscle fibers, and adipose layers was evident along with a diminished number of hair follicles and sebaceous glands (Fig. 6b) . Focal parakeratosis and scaling was readily detectable in dorsal and abdominal skin (Fig. 6c ) and in ear cross-sections (Fig. 6e, f) . Dyskeratosis (apoptosis) in the basal layer of cells was increased and extended to the mid-epidermis. A mild dermal acute inflammatory infiltrate could be detected in longer-lived animals, but not in all cases. Dilated blood vessels were found in the dermal layer of cells of ear sections. The mixed dermal acute and chronic inflammation was more prominent in ears relative to the dorsal or abdominal skin (Fig. 6e, f) .
Histologic examination of lung tissues (Fig. 7a, b ) revealed interstitial thickening caused primarily by mononuclear inflammatory cells and some polymorphonuclear neutrophils (PMNs), consistent with interstitial pneumonia, possibly contributing to death. Occasionally, foamy macrophages could be seen in the interstitium and air spaces. In the spleen, increased plasma cells in the red pulp could be detected along with an increased number of foamy macrophages (Fig. 7f, g ). Histology of liver, heart, and pancreas revealed no obvious histologic abnormalities (not shown).
Esr1/Cre leakage results in a premature aging phenotype and death To establish a different (tamoxifen-inducible) Cre-mediated recombination system, B6.Cg-Tg(cre/Esr1)5Amc/J transgenic mice (The Jackson Laboratory) (Hayashi and McMahon 2002) were used to generate Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl and Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl
animals. The Actb-Esr1/Cre conditional system utilizes a fusion protein composed of Cre and the ligand-binding domain of the estrogen receptor (Esr1). The estrogen receptor domain was mutated to render it unable to bind its natural ligand (17b-estradiol) but be responsive to 4-hydroxy tamoxifen (Danielian et al. 1998; Fawell et al. 1990; Littlewood et al. 1995) . The estrogen receptor domain interacts with Hsp90 causing cytoplasmic sequestration of the Cre/Esr1 fusion protein (Mattioni et al. 1994; Picard 1994 ), thus preventing Cre-mediated recombination in the nucleus. Exposure to 4-hydroxy tamoxifen disrupts the interaction between Esr1 and Hsp90, permitting the migration of the fusion Cre/Esr1 protein to the nucleus and initiation of recombination. In the Actb-Esr1/Cre system, Cre/Esr1 is expressed from a chimeric promoter/enhancer of the cytomegalovirus immediate-early enhancer and the chicken-globin promoter/enhancer (Actb) that elicits widespread spatial expression in adult and embryonal tissues (Hayashi and McMahon 2002) . We first assessed the survival rates of Actb-Cre Supv3L1 tm2Jkl/tm2Jkl , Actb-Cre Supv3L1 tm3Jkl/tm4Jkl , Actb-Cre Supv3L1 tm3Jkl/? , and Actb-Cre Supv3L1 tm2Jkl/? animals without administration of tamoxifen (Fig. 4b) . While control mice carrying one wild-type allele of Supv3L1 were normal and no deaths were recorded in the time frame of the experiment, the lifespan of Actb-Cre Supv3L1 tm2Jkl/tm2Jkl and Actb-Cre Supv3L1 tm3Jkl/tm4Jkl animals was short, averaging approximately 10 weeks. Thus, similar to Mx1-Cre, the Actb-Esr1/Cre system displays a measurable degree of leakage causing the removal of exon 14 of the Supv3L1 gene. The gross phenotypic appearance caused by Actb-Esr1/Cre leakage included kyphosis, sarcopenia, and lack of fat tissue (Fig. 2d) . The dystrophic muscles and general cachexia led to a decline in locomotor functions (not shown). Thymic atrophy was striking (Fig. 2e) . The exon 14 deletion was partial and progressed to different extents in different tissues, with muscle and pancreas being the most affected (Fig. 5c) .
Histologic examination of the skin (Fig. 6g ) revealed loss of adipose cells and muscle fibers. In the lung, thickening of interstitial layers of cells with focal mild chronic and acute inflammation could be detected (Fig. 7c) . No histopathologic changes were seen in heart muscle, liver, and spleen. Thus, noninduced and Actb-Esr1/Cre-driven Supv3L1 disruption leads to general dystrophic changes, many of them being reminiscent of premature aging.
Subcutaneous injection of tamoxifen enhances cachexia, kyphosis, and skin defects Although noninduced Actb-Esr1/Cre leakage was sufficient to elicit clear phenotypes, it was reasonable to expect that further stimulation with tamoxifen would result in accelerated and more pronounced changes and uncover additional consequences of exon 14 removal. tm2Jkl/? mouse. Ad, adipose layer; Der, dermis; Eder, epidermis; SC, subcutaneous muscle fibers. b Skin from an age-matched Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animal. HC, hyperkeratosis. Note the thickened epidermis, severe hyperkeratosis, dystrophic dermis, lack of sebaceous glands, and almost total absence of adipose and muscle layers. c Higher-power magnification of the skin from an Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animal showing parakeratosis (arrow) and scaling. d Cross-section of a normal ear of an Mx1-Cre Supv3L1 tm2Jkl/? animal at 10 weeks of age. e Cross-section of an ear of an age-matched Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl animal showing disfigured morphology, thickened epidermis, hyperkeratosis, and neutrophilic microabscesses (arrowhead). f Another Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl cross-section showing an hyperkeratotic area with absent epidermal cells (arrowhead). g H&E-stained skin section of an Actb-Cre Supv3L1 tm2Jkl/tm2Jkl animal at the age of 12 weeks. h Dorsal skin from an Actb-Cre Supv3L1 tm2Jkl/tm2Jkl animal injected subcutaneously with tamoxifen at the age of 25 days. Note the absence of adipose tissue, paucity of subcutaneous muscle, dilated blood vessels, and mild hyperkeratosis. i Skin from the control animal (Actb-Esr1/Cre Supv3L1 tm2Jkl/? ) topically treated with 4-hydroxy tamoxifen. j A skin sample from an Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl animal after topical 4-hydroxy tamoxifen treatment. Note hyperkeratotic and parakeratotic changes along with a significantly thickened epidermal layer of cells. Dilated blood vessels in the dermal layer are marked with asterisks. k Ear cross-section of a control KRT14-Cre/Esr1 Supv3L1 tm3Jkl/? mouse after subcutaneous administration of tamoxifen. Biopsy was taken 4 weeks after subcutaneous administration was completed. l Ear cross-section of a KRT14-Cre/Esr1 Supv3L1 tm3Jkl/tm4Jkl littermate of the same sex and age after subcutaneous administration of tamoxifen. Note atrophy of hair follicles, sweat glands, thickening of epidermis, hyperkeratosis, dilation of blood vessels, and infiltrative changes Fig. 7 Histology of the lung, spleen, and duodenum. a Mx1-Cre Supv3L1 tm2Jkl/? and b Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl lung at 7 weeks. Note an increased number of inflammatory cells and edema. c H&E-stained section of the lung from an Actb-Cre Supv3L1 tm2Jkl/tm2Jkl
animal at the age of 12 weeks. Note the increased number of inflammatory cells, congestion, and edema. d Lung from a control Actb-Cre Supv3L1 tm2Jkl/? animal injected subcutaneously with tamoxifen at the age of 25 days. e Lung from an Actb-Cre Supv3L1 tm2Jkl/tm2Jkl animal injected subcutaneously with tamoxifen at the age of 25 days. Note the increased number of inflammatory cells, congestion, and edema. f H&E-stained section of the spleen from a control Mx1-Cre Supv3L1 tm2Jkl/?
mouse. g Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl spleen at 7 weeks. Note splenic atrophy. h TUNEL assay performed on a cross-section of the duodenum from an Actb-Cre Supv3L1 tm2Jkl/tm2Jkl control littermate injected subcutaneously with tamoxifen at the age of 25 days. Note the low number of TUNEL-positive cells. i The same assay performed on the duodenum from an Actb-Cre Supv3L1 tm2Jkl/tm2Jkl animal also injected with tamoxifen. Note numerous TUNEL-positive cells. j Quantification of apoptotic cells in panels h and i
The effects of subcutaneous administration of tamoxifen were tested using Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl , Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl , and Actb-Esr1/Cre Supv3L1 tm2Jkl/? (control) animals at the age of 3.5 weeks. Dramatic changes in growth, adipose tissue loss, sarcopenia, thymic atrophy, kyphosis (Fig. 2f) , and body weight loss were evident in Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl but not in Actb-Esr1/Cre Supv3L1 tm2Jkl/? (control) animals. These changes occurred faster relative to noninduced changes.
The development of scales was detectable on limbs ( Fig. 2g) and tails. The skin of the body showed no obvious hair loss, although gene inactivation was widespread and almost complete (over 90% conversion into D14) in several different organs, including skin (Fig. 5d) . The largest fraction of intact (floxed) Supv3L1 allele remained in the liver, spleen, lungs, duodenum, and testes. Control animals (carrying one wild-type allele) displayed no tamoxifeninducible phenotypes but did display a measurably greater loss of the floxed allele. This result raises the possibility that in Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl mice, replacement of dying cells from a pool of still unaffected stem cells (homozygous or heterozygous for exon 14) may be occurring, particularly in the spleen and liver. Actb-Esr1/ Cre induction with tamoxifen shortened the lifespan of Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl
and Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl mice ( Fig. 4c ) and all animals died before reaching their 10th week of age.
Histopathology of skin samples isolated from tamoxifen-induced Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl and ActbEsr1/Cre Supv3L1 tm3Jkl/tm4Jkl mice was different relative to untreated animals and revealed fewer sebaceous glands and mild hyperkeratosis, acanthosis, and hypergranulosis, as well as increased apoptosis in the basal layer of cells (Fig. 6h) . Focal vascular ectasia was evident along with an absence of adipose tissue and a greatly atrophic muscle layer. Microscopic abscesses and mild dermal acute and chronic inflammation changes were apparent. In the lung, changes such as interstitial thickening with chronic and acute inflammation and focal accumulation of foamy macrophages were found (Fig. 7d, e) . Although no obvious histologic changes could be detected in the duodenum, substantially elevated levels of apoptosis were evident in the Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl mice (Fig. 7i) relative to the control Actb-Esr1/Cre Supv3L1 tm3Jkl/? animals ( Fig. 7h, j) . Subcutaneous delivery of tamoxifen did not result in detectable alopecia.
Tamoxifen-induced ablation of Supv3L1 perturbs T-cell precursors in the thymus
Previous analysis indicated that conditional ablation of the Bloom syndrome (BLM) helicase, an in vitro interactor of SUPV3L1 (Pereira et al. 2007 ), impaired development of T lineage cells in the thymus (Babbe et al. 2007) . Accordingly, we asked whether ablation of the Supv3L1 gene would perturb T-cell development. Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl , Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl , and Actb-Esr1/Cre Supv3L1 tm2Jkl/? (control) mice were injected subcutaneously with tamoxifen at the age of 4 weeks and thymocytes and splenocytes were isolated 10-15 days after the completion of the injection schedule. Indeed, thymic cellularity was reduced substantially (approximately sixfold), affecting all subpopulations defined by differential expression of CD4 ? 8?, , although immature populations appeared to be preferentially depleted (Fig. 8a) . Among the least mature CD4-8-double-negative (DN) population, the most profoundly affected subpopulations were DN3 (CD44-CD25 ?) and DN4 (CD44-CD25-) cells, whose survival is dependent upon signaling through the pre-T-cell receptor (TCR) complex (Fig. 8b) (Hoffman et al. 1996) . Moreover, these effects appear to be more evident in the ab TCR-expressing lineage than in cd lineage DN thymocytes (Fig. 8c) . Immature DN3 thymocytes are induced to develop to the DN4 stage and ultimately to the CD4 ? 8 ? double-positive (DP) stage by pre-TCR signaling (Fehling et al. 1995) . Either this transition or the survival of DP thymocytes is impaired by Supv3L1 deficiency, because the absolute number of DP thymocytes was reduced more than tenfold in Actb-Esr1/Cre Supv3L1 tm2Jkl/ tm2Jkl mice (Fig. 8a) . TCR-induced differentiation of DP thymocytes into mature CD4 ? or CD8 ? single-positive (SP) thymocytes appears to be less sensitive to Supv3L1 ablation, as the absolute number of mature CD69lo thymocytes was actually increased. Likewise, mature T cells in the spleen (Fig. 8f ) and skin were not substantially affected. Taken together, these data suggest that immature thymocytes are sensitive to the loss of the Supv3L1 gene. This is unlikely to be an indirect effect of Supv3L1-deficiency-induced stress on thymocytes because stressinduced death of thymocytes is usually directed against DP thymocytes, whereas we also observed losses of immature DN subsets.
Topical 4-hydroxy tamoxifen application induces localized skin changes
To examine more localized, 4-hydroxy tamoxifen-inducible changes in the skin, Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl
and Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl mice had the drug applied to areas of shaved back skin, a site that is not easily accessible for self-grooming, scratching, and mechanical irritation. Mice were separated from their littermates and kept individually for the duration of the experiment. Seven days after completion of the treatment schedule, erythromatous reaction and scaling had developed at the application site in Actb-Cre Supv3L1 tm2Jkl/tm2Jkl and ActbEsr1/Cre Supv3L1 tm3Jkl/tm4Jkl animals but not in Actb-Esr1/ Cre Supv3L1 tm2Jkl/? and Actb-Esr1/Cre Supv3L1 tm3Jkl/?
(control) mice. In the skin biopsies taken for analysis, exon 14 of the Supv3L1 gene was efficiently deleted (Fig. 5e ). The subcutaneous vasculature was more prominent in the Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl skin relative to control skin. H&E staining revealed that in the skin of animals carrying both floxed alleles, the epidermis was thickened, revealing hyperkeratosis, parakeratosis, acanthosis, and hypergranulosis, while dermal blood vessels were dilated relative to Actb-Esr1/Cre Supv3L1 tm2Jkl/? animals ( Fig. 6i, j) .
However, hair follicle and sebaceous gland loss was not detectable at this stage, likely because of the short period of time between 4-hydroxy tamoxifen stimulation and skin biopsy collection. This response was indistinguishable between Actb-Cre Supv3L1 tm2Jkl/tm2Jkl and Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl animals and, therefore, unrelated to the presence or absence of the Neo cassette (not shown).
Over time, further phenotypic changes occurred. The Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl and Actb-Cre Supv3L1 tm2Jkl/tm2Jkl mice continued to lose weight (Fig. 3b) , eventually becoming sarcopenic, kyphotic, and occasionally ataxic (not shown). The deletion of exon 14 appeared to be close to complete just before death in most Fig. 8 Flow cytometric analysis of thymic T-cell progenitors and mature spleen T cells. Thymocytes (a-e) and splenocytes (f) were analyzed by flow cytometry using monoclonal antibodies reactive with the following differentiation antigens (a-f): CD4, CD8, CD69, TCRb, CD25, CD44, TCRcd, CD24, Thy1.2, and B220. Gate frequencies are listed in the quadrants of the histograms. Absolute numbers of populations were calculated from gate frequencies and are represented graphically on the right side of the figure. Tot. Thy., total thymocyte; DP, double positive; DN, double negative; SP, single positive; Tot. Spl., total splenocyte. Supv3L1 fl/? and fl/? refer to a control, tamoxifen-injected Actb-Esr1/Cre Supv3L1 tm2Jkl/? mice displaying no phenotype. Supv3L1 fl/-and fl/-refer to Actb-Esr1/Cre Supv3L1 tm3Jkl/ tm4Jkl and Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl mice that display phenotypes after tamoxifen induction tissues (Fig. 5f) , suggesting an efficient absorption of the drug through the skin. No phenotypes were detected in control mice (Actb-Esr1/Cre Supv3L1 tm3Jkl/? or Actb-Cre Supv3L1 tm2Jkl/? ) treated with 4-hydroxy tamoxifen.
Skin defects inducible by keratinocyte-specific Supv3L1 disruption
Although important in several tissues such as epithelia of the tongue, mouth, esophagus, forestomach, and the thymic epithelium, the keratin 14 (KRT14) gene is expressed primarily in keratinocytes (Lloyd et al. 1995; Moll et al. 1982; Wang et al. 1997) . Thus, the KRT14 promoter is widely used to drive expression of various genes in the epidermis (Magin 1998) . To generate KRT14-Cre/Esr1 Supv3L1 tm3Jkl/ tm4Jkl animals, we used the Tg(KRT14-Cre/Esr1)20Efu/J strain of mice (Vasioukhin et al. 1999) . These mice carry a KRT14-driven transgene encoding Cre/Esr1. Thus, upon tamoxifen administration, disruption of the Supv3L1 gene in KRT14-Cre/Esr1 Supv3L1 tm3Jkl/tm4Jkl mice can be achieved primarily in the epidermal layer of cells.
KRT14-Cre/Esr1 Supv3L1 tm3Jkl/tm4Jkl
and control KRT14-Cre/Esr1 Supv3L1 tm3Jkl/? mice at 5 weeks of age were injected subcutaneously with tamoxifen. Three weeks later, the KRT14-Cre/Esr1 Supv3L1 tm3Jkl/tm4Jkl animals showed disfiguring, erythromatous swelling of the ears while control animals appeared normal. H&E-stained crosssections of ear biopsies taken from a control mouse showed no apparent changes due to tamoxifen administration (Fig. 6k) . In contrast, ear biopsies from injected KRT14-Cre/Esr1 Supv3L1 tm3Jkl/tm4Jkl animals revealed disfiguring lesions along with hyperkeratosis acanthosis, parakeratosis, and scaling (Fig. 6l) . The epidermis was thickened, while dermal layers showed signs of chronic inflammation marked by apoptosis and the presence of focal intraepithelial lymphocyte infiltrates. Dilated blood vessels were readily detectable. KRT14-Cre/Esr1 Supv3L1 tm3Jkl/tm4Jkl mice, however, did not suffer from loss of fat, muscle mass, body weight, or body hair loss for at least 3 months after tamoxifen administration, and no other pathologic changes could be detected within this time frame. Compared with that in the ears, the above changes were less pronounced in body skin. Since the keratinocyte-restricted Supv3L1 disruption leads to dramatic changes such as hyperkeratosis, scaling, and infiltrative immune responses without apparent effects on other organ systems, Supv3L1 function is critical for the maintenance and proper function of the epidermis.
Discussion
The Supv3L1 gene is developmentally regulated and mouse embryos carrying a homozygous insertional mutation die in utero before midgestation (Pereira et al. 2007 ). Expression of the Supv3L1 gene in adult mammalian tissues has been reported to be widespread (Dmochowska et al. 1999) . To obtain insights into the function of the Supv3L1 helicase in adult life, we constructed a conditional mutation by floxing exon 14 and generated mice carrying this allele. In agreement with the previous insertional mutation, we found that homozygous deletion of exon 14 in the germ line leads to an embryonic lethal phenotype, while heterozygous animals are normal and indistinguishable from their wild-type littermates for the first 12 months of life. Thus, the exon 14 removal appears to constitute a recessive hypomorphic mutation. We subsequently combined the floxed allele with three different Cre-driver systems: Two of them (Mx1-Cre and Actb-Esr1/Cre) provided widespread gene inactivation patterns corresponding with the widespread expression of Supv3L1, while the third one (KRT14-Cre/Esr1) was limited mostly to keratinocytes and was chosen to confirm defects in the skin. Since three different Cre drivers were applied to the same floxed allele, direct comparison of phenotypic similarities and differences between these systems was possible.
Supv3L1 gene inactivation using the Mx1-Cre system The most striking phenotype was severe growth retardation and numerous abnormalities in the skin. A very characteristic flattening and deformity of the ears could be used with great precision for visual genotyping as early as 2-3 weeks of age. Severe alopecia and mild kyphosis were observed in animals that survived to 2 months. Exon 14 deletion was progressive and almost complete in the skin, while other tissues displayed a variable degree of inactivation, likely reflecting the mosaic population of Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl (floxed), Mx1-Cre Supv3L1 tm2Jkl/tm5Jkl
(heterozygous), and Mx1-Cre Supv3L1 tm5Jkl/tm5Jkl (D14 homozygous) cells present in these organs. Consistently, the earliest and strongest phenotypes were seen in the skin. Profound scaling developed over the entire epidermis, including feet, tail, and ears. Hyperkeratosis and focal parakeratosis were readily detectable in skin and ear crosssections, which, along with an abnormally thickened epidermis, are suggestive of epidermal hyperproliferation. Microabscesses were not frequent but occasionally evident.
One intriguing question is the mechanism of Mx1-Cre induction in our animals. The Mx1 gene belongs to a family of a virus-resistance loci that are silent in healthy animals but strongly induced during the interferon response to infection (Arnheiter et al. 1990 ). Hence, either interferon or poly(I-C) injection is typically used in the Mx1-Cre system to induce Cre expression, which was reported to be greatest in the liver, spleen, and hematopoietic cells (close to 100%), and somewhat lower in the kidney, heart, and lung (Kuhn et al. 1995) . However, we found that no induction was necessary to elicit the profound pathologic changes and ultimately death, as described above. A certain degree of intrinsic ''leakage'' of the Mx1-Cre system has been amply documented but is unlikely to lead to the extensive deletion of a floxed allele that we have observed. One possibility is that initial deletion caused by intrinsic leakage leads to sufficient cellular damage to trigger an interferon response, thus creating a feed-forward amplifying loop. In this context it should be noted that the epidermis is the main barrier to environmental insults, and that epidermal hyperplasia often arises due to an innate immune response involving a variety of cytokines. Many of the symptoms seen in our Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl mice resemble those found in psoriasis, such as thickening of the epidermis, hyperkeratosis, parakeratosis, prominent scaling, microabscesses, and alopecia (Boehncke and Schon 2007; Gudjonsson et al. 2007; Schon 1999) . Many of these skin changes are believed to be driven by a leukocytic infiltrate composed of activated T lymphocytes, neutrophils, and macrophages. Although the involvement of immunologic mechanisms in the phenotypic changes observed in Mx1-Cre Supv3L1 tm2Jkl/tm2Jkl mice clearly requires further study, we believe it is likely that immune cells augment Supv3L1 deletion by supplying Mx1-Creinducing cytokines, first within the skin but subsequently also in a systemic fashion.
Supv3L1 inactivation using the Actb-Esr1/Cre and KRT14-Cre/Esr1systems
Similar to Mx1-Cre, in the Actb-Esr1/Cre system sufficient deletion of floxed Supv3L1 occurred in the absence of exogenous induction with tamoxifen to elicit pronounced phenotypes and eventually death. The gross phenotypic changes included kyphosis, sarcopenia, complete loss of fat tissue, thymic atrophy, and atrophic changes in the skin. Administration of tamoxifen by subcutaneous injection significantly accelerated and exacerbated the development of phenotypes such as growth retardation and loss of adipose tissue and muscle mass, which contributed to cachectic appearance at time of death. Severe kyphosis developed within several of weeks after drug administration. Scaling was prominent on feet and tails, a phenotype that was seen in the Mx1-Cre mice but did not appear in Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl or Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl mice without tamoxifen administration. In the body skin, mild hyperkeratosis was seen after induction of Cre, while no hyperkeratosis was seen in the absence of tamoxifen. In contrast, when 4-hydroxy tamoxifen was applied topically to shaved backs of animals, severe skin phenotypes developed. The differences in the severity of the skin phenotypes elicited by different methods of Cre induction may be related to the corresponding spatial and temporal efficiencies of floxed allele deletion. In addition, defects in innate immune functions, e.g., in the spleen and thymus due to Supv3L1 deletion, and their subsequent effects on the responses manifested in the skin could also contribute to phenotypic differences. A variety of additional phenotypic differences were seen in the topical and subcutaneous Cre-inducing drug delivery routes. For example, subcutaneously injected mice developed scaling of feet and tails, while topical application did not elicit such changes. The development of sarcopenia and kyphosis was seen with both of the drug delivery routes, but it was also achievable without Cre induction. Finally, when the same delivery route was applied, Supv3L1 disruption in different genotypes (i.e., Actb-Esr1/Cre Supv3L1 tm2Jkl/tm2Jkl and Actb-Esr1/Cre Supv3L1 tm3Jkl/tm4Jkl mice) led to similar changes. Thus, the presence or absence of the Neo cassette in the targeted locus had no effect on the experimental outcome. Keratinocyte-restricted Supv3L1 ablation recapitulated, to a significant extent, the skin phenotypes elicited in the Mx1-Cre and Actb-Esr1/Cre systems, such as ear lesions, hyperkeratosis, scaling, thickening of epidermis, dilation of blood vessels, and neutrophilic infiltration. Because other organs did not suffer from Supv3L1 deletion, gross systemic phenotypes were not observed. The KRT14-Cre/ Esr1system thus reinforces the notion that Supv3L1 activity in the epidermis is important and necessary for the maintenance of its protective barrier function. Taken together, the results obtained with all three Cre-induced ablation systems strongly implicate Supv3L1 in the maintenance of normal and healthy skin function. Immune changes resulting from compromised Supv3L1 helicase activity also warrant further examination as possible contributors in debilitating skin diseases such as psoriasis or certain forms of ichthyosis of unknown etiology.
Role of Supv3L1
Yeast Suv3 is involved in the processing of mitochondrial RNA precursors (Dziembowski et al. 2003; Margossian et al. 1996; Stepien et al. 1992) . In C. elegans, RNAi ablation of Suv3 is lethal at early embryonic stages (Maeda et al. 2001) . Human SUPV3L1 helicase was reported to modulate apoptotic responses ), elevate sister chromatid exchange, and interact with the BLM and WRN proteins (Pereira et al. 2007 ). However, the primary molecular function appears to involve mtRNA processing. In the absence of SUPV3L1, aberrant mtRNA turnover has been shown to impair mitochondrial protein synthesis and ATP production, lower the mtDNA copy number and membrane potential, and increase the generation of ROS collectively leading to cellular senescence and cell death (Khidr et al. 2008 ).
Mitochondrial dysfunction can cause a wide range of disorders (Taylor and Turnbull 2005) such as progressive external ophthalmoplegia (PEO), Pearson's syndrome (PS), or Kearns-Sayre syndrome (KSS). The mouse mutant of Twinkle, a nuclearly encoded mtDNA helicase, displayed PEO, accumulation of multiple mtDNA deletions, and progressive respiratory dysfunction: (Tyynismaa et al. 2005) Extensive deletions in mitochondrial DNA are believed to be the result of polymerase stalling during replication, leading to deletions forming at direct repeats (Wanrooij et al. 2004) . In mtDNA diseases, the affected tissues are typically those with a high energy demand such as muscle and brain (Taylor and Turnbull 2005) , resulting in symptoms similar to those associated with neurodegenerative diseases.
Although SUPV3L1 localizes primarily to the mitochondrial matrix, nuclear localization has also been well documented ). BLM and WRN are well-characterized genome stability housekeepers whose disruption leads to Bloom and Werner syndromes, respectively (Hickson 2003) . Genomic integrity maintenance pathways are increasingly being linked not only to a variety of diseases but also to natural and accelerated aging processes. Interestingly, knockout mouse models of other helicases with important roles in DNA repair and genome maintenance display striking and overlapping phenotypic similarities to the Supv3L1 phenotypes. For example, trichothiodystrophy mice (de Boer et al. 1998 ) carrying a mutation in the xeroderma pigmentosum (XPD) gene, which is involved in the nucleotide excision repair NER pathway, show ichthyosis and hyperkeratosis, growth retardation, adipose tissue hypoplasia, reduced lifespan, and a prematurely aged appearance. Disruption of PASG (proliferation-associated SNF-2-like gene) or lsh (lymphocyte-specific helicase), which encodes a SNF-2-like protein involved in genome methylation, causes growth retardation and premature aging symptoms such as hyperkeratosis, alopecia, reduced fat deposition, cachexia, and kyphosis (Sun et al. 2004 ).
There are also overlapping phenotypic similarities between knockouts of Supv3L1 and other RecQ helicases, as well as human syndromes resulting from mutations in these genes. For example, Rothmund-Thomson syndrome (RTS), associated with mutations in the RecQL4 helicase and is clinically characterized by limb defects, frequent osteoporosis, hypogonadism, infertility, and juvenile cataracts, also displays skin changes such as congenital poikiloderma, telangiectases, atrophic hyperkeratosis, photosensitivity, and blistering (Vennos and James 1995; Vennos et al. 1992) . Mouse models of RTS show growth retardation, atrophy of numerous tissues, alopecia, and scaling of the tail (Hoki et al. 2003; Mann et al. 2005 ). Many of these phenotypes were seen in our studies of Supv3L1 ablation using one or more inducible Cre systems. Werner's syndrome, a premature aging disease caused by mutations in the WRN gene, is characterized by atherosclerosis, short stature, hypogonadism, premature thinning and graying leading to balding of the scalp, thin skin with telangiectases and ulceration, patchy hypopigmentation and hyperpigmentation, skin wrinkling, lymphoid depletion, and thymic atrophy (Nehlin et al. 2000) . The in vitro interaction of SUPV3L1 and WRN has been documented (Pereira et al. 2007) , and some phenotypic similarities between clinical WRN features and Supv3L1 ablated mice could be noted. Finally, clinical characteristics of Bloom syndrome include short stature, short lifespan, telangiectaticerythema in a butterfly distribution on the face in response to sun exposure, short stature, and immunodeficiency (German 1995) . Some of the Bloom characteristics overlap with those seen in our model mice, particularly short stature and short lifespan, while strong in vitro binding of human BLM to the SUPV3L1 protein points to importance in genome maintenance pathways (Pereira et al. 2007) .
A specific human disease associated with germ line or somatic mutations in the SUPV3L1 gene has not emerged to date. SUPV3L1 maps to chromosome 10q22 (Rogers et al. 2000; Thomas et al. 2001 ), a region implicated in the hereditary motor and sensory neuropathy russe (HMSNR) syndrome, a hereditary autosomal recessive form of demyelinating motor and sensory neuropathy known as Charcot-Marie-Tooth disease type 4 (CMT4). Recent genetic studies narrowed the critical region of HMSNR to 111 kb (Hantke et al. 2003) . Although these studies failed to identify the disease gene, SUPV3L1 is present in this region, raising the possibility it may be involved in disorders affecting the peripheral nervous system. In the mouse, the widespread expression of Supv3L1 in embryonal tissues diminishes somewhat in adulthood but remains high in the brain and peripheral sensory tissues such as retina (not shown).
Depending on the tissue type and extent of Supv3L1 gene deletion, the phenotypes of our conditional knockout mice range from severe disfiguring, ichthyosis-like, or psoriatic-like changes in the skin to sarcopenic, premature aging-like changes if multiple tissues are affected. Aging mechanisms are partially understood at molecular, cellular, or organism levels. The complexity of aging is reflected by the very large number of genes implicated in aging progression (Slijepcevic 2007) , and numerous hypotheses that have been put forth to try to explain the molecular aspects of these phenomena. The somatic mutation theory assumes progressive decline of cellular capacity to respond to DNA damage (Promislow 1994) . The telomere hypothesis invokes the loss of telomeric DNA as an important aspect of cellular senescence and depletion of stem cell pools (Collado et al. 2007 ). The oxidative stress theory implicates mitochondrial alterations in aging (Giorgio et al. 2007) , while the chromatin reorganization model implies alterations in nuclear architecture (Oberdoerffer and Sinclair 2007) . Finally, the altered proteins accumulation (Terman and Brunk 2004) , cellular senescence (Campisi and d'Adda di Fagagna 2007) , and adult stem cells decline (Sharpless and DePinho 2007) theories were also put forward. All these models have one common denominator: the accumulation of molecular, cellular, or tissue damage with age (Slijepcevic 2007) . Although germ line mutation of Supv3L1 is embryonic lethal, in a somatic environment impaired functional activity of Supv3L1 emerges as a contributing factor that can affect processes within many of the above theoretical frameworks. The recently reported Spuv3L1-dependent processing of mammalian mtRNA molecules (Khidr et al. 2008 ) offers one possible, cascadelike mechanism, whose impairment may lead to mitochondrial dysfunction, consequent cellular senescence, and ultimately cell death, all of which correlate well with and could contribute to the phenotypic changes described in this work.
